Novartis Wins Ruling On Duty-To-Warn Scope In Zometa Suit
By Nathan Hale ( July 1, 2014, 10:16 PM EDT) -- A Florida federal court on Tuesday granted Novartis Pharmaceuticals Corp.'s request to exclude evidence and argument on claims that it had a duty to warn people beyond the prescribing physician of possible side effects of a pair of cancer drugs....
Law360 is on it, so you are, too.
A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.
A Law360 subscription includes features such as
- Daily newsletters
- Expert analysis
- Mobile app
- Advanced search
- Judge information
- Real-time alerts
- 450K+ searchable archived articles
And more!
Experience Law360 today with a free 7-day trial.